Related Experiment Video
Updated: May 23, 2026

09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
How do tumor stem cells actively escape from host immunosurveillance?
Yao Qi1, Run-Mei Li, Fan-Ming Kong
1Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Biochemical and Biophysical Research Communications
|April 3, 2012
Summary
Tumor stem cells (TSCs) are key drivers of cancer growth and spread. This review explores how TSCs evade the immune system, hindering effective cancer therapies.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Tumor stem cells (TSCs) drive tumor development, metastasis, and recurrence.
- TSCs possess properties enabling immune evasion, challenging host immunosurveillance.
- Understanding TSC immune escape is crucial for developing effective cancer treatments.
Purpose of the Study:
- To review the latest findings on mechanisms of tumor stem cell immune escape.
- To elucidate how TSCs evade immune recognition and destruction.
- To provide insights into TSCs' role in cancer biology, prevention, and therapy.
Main Methods:
- Review of recent mechanistic studies on tumor stem cells and immunology.
- Analysis of literature on TSC-mediated immune evasion strategies.
- Synthesis of information on the tumor microenvironment's role in immune escape.
Main Results:
- TSCs employ multiple strategies to evade immune attack, including altered immunogenicity and regulatory molecule production.
- Interactions between TSCs and tumor-infiltrating immune cells contribute to immune escape.
- The tumor microenvironment, including mesenchymal cells and cytokines, supports TSC immune evasion.
Conclusions:
- TSCs actively subvert immune responses through intrinsic and extrinsic mechanisms.
- Targeting TSC immune evasion pathways presents a promising therapeutic strategy for solid tumors.
- Further research into TSC-immune interactions is essential for advancing cancer therapy.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

